Your browser doesn't support javascript.
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells.
Schulien, Isabel; Kemming, Janine; Oberhardt, Valerie; Wild, Katharina; Seidel, Lea M; Killmer, Saskia; Daul, Franziska; Salvat Lago, Marilyn; Decker, Annegrit; Luxenburger, Hendrik; Binder, Benedikt; Bettinger, Dominik; Sogukpinar, Oezlem; Rieg, Siegbert; Panning, Marcus; Huzly, Daniela; Schwemmle, Martin; Kochs, Georg; Waller, Cornelius F; Nieters, Alexandra; Duerschmied, Daniel; Emmerich, Florian; Mei, Henrik E; Schulz, Axel Ronald; Llewellyn-Lacey, Sian; Price, David A; Boettler, Tobias; Bengsch, Bertram; Thimme, Robert; Hofmann, Maike; Neumann-Haefelin, Christoph.
  • Schulien I; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kemming J; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Oberhardt V; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Wild K; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Seidel LM; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Killmer S; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Sagar; Faculty of Chemistry and Pharmacy, University of Freiburg, Freiburg, Germany.
  • Daul F; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Salvat Lago M; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Decker A; SGBM - Spemann Graduate School of Biology and Medicine, University of Freiburg, Freiburg, Germany.
  • Luxenburger H; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
  • Binder B; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Bettinger D; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Sogukpinar O; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Rieg S; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Panning M; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Huzly D; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schwemmle M; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kochs G; IMM-PACT, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Waller CF; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Nieters A; IMM-PACT, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Duerschmied D; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Emmerich F; Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Mei HE; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schulz AR; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Llewellyn-Lacey S; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Price DA; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Boettler T; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Bengsch B; Institute of Virology, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Thimme R; Department of Haematology, Oncology & Stem Cell Transplantation, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Hofmann M; Center for Biobanking-FREEZE-Biobanking, Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Neumann-Haefelin C; Department of Medicine III (Interdisciplinary Medical Intensive Care), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Nat Med ; 27(1): 78-85, 2021 01.
Article in English | MEDLINE | ID: covidwho-1065910
ABSTRACT
Emerging data indicate that SARS-CoV-2-specific CD8+ T cells targeting different viral proteins are detectable in up to 70% of convalescent individuals1-5. However, very little information is currently available about the abundance, phenotype, functional capacity and fate of pre-existing and induced SARS-CoV-2-specific CD8+ T cell responses during the natural course of SARS-CoV-2 infection. Here, we define a set of optimal and dominant SARS-CoV-2-specific CD8+ T cell epitopes. We also perform a high-resolution ex vivo analysis of pre-existing and induced SARS-CoV-2-specific CD8+ T cells, applying peptide-loaded major histocompatibility complex class I (pMHCI) tetramer technology. We observe rapid induction, prolonged contraction and emergence of heterogeneous and functionally competent cross-reactive and induced memory CD8+ T cell responses in cross-sectionally analyzed individuals with mild disease following SARS-CoV-2 infection and three individuals longitudinally assessed for their T cells pre- and post-SARS-CoV-2 infection. SARS-CoV-2-specific memory CD8+ T cells exhibited functional characteristics comparable to influenza-specific CD8+ T cells and were detectable in SARS-CoV-2 convalescent individuals who were seronegative for anti-SARS-CoV-2 antibodies targeting spike (S) and nucleoprotein (N). These results define cross-reactive and induced SARS-CoV-2-specific CD8+ T cell responses as potentially important determinants of immune protection in mild SARS-CoV-2 infection.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-020-01143-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-020-01143-2